| Title | Adult Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia-biomarker data-D150 |
|---|---|
| Description | For drugs such as inclisiran that have been approved by major health authorities (HAs) worldwide but not in China, several special territories in China can provide drug early access to Chinese patients. A real-world evidence study in these territories can provide data of effectiveness and safety of inclisiran in Chinese population. This study will utilize real-world data from EMR database to serve as the "external control". The purpose of this study is to compare the effectiveness of inclisiran as an add-on therapy (or monotherapy in statin-intolerant cases) in real-world settings with current SoC in a matched historical cohort of patients who receive SoC in EMR database. |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA014844 |
| Release Date | 2023-02-11 |
| Submitter | shijuan lu (1157416676@qq.com) |
| Organization | Haikou people's Hospital |
| Submission Date | 2023-02-09 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download |
|---|---|---|---|---|---|---|
| OMIX002952-01 | Biomarker data | 54 | Biomarker Data | 58.6 KB | xlsx | Controlled |
| Paper Title | Journal Name | Publish Time | Accession | Citing Type |
|---|